Arcutis Biotherapeutics, Inc. ARQT Change in AR
Change in AR at other companies
Other financials
Where this comes from
Reported directly by Arcutis Biotherapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:IncreaseDecreaseInAccountsReceivable.
The official record: Arcutis Biotherapeutics, Inc.’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →
Ask your AI about Arcutis Biotherapeutics, Inc.'s change in ar.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Arcutis Biotherapeutics, Inc.'s change in AR?
- Arcutis Biotherapeutics, Inc. (ARQT) reported change in AR of -$1.85M in Q1 2026.
- How has Arcutis Biotherapeutics, Inc.'s change in AR changed year-over-year?
- Arcutis Biotherapeutics, Inc.'s change in AR decreased by 115.0% year-over-year, from $12.35M to -$1.85M.
- What is the long-term trend for Arcutis Biotherapeutics, Inc.'s change in AR?
- Over 3 years (2022 to 2025), Arcutis Biotherapeutics, Inc.'s change in AR has grown at a 105.3% compound annual growth rate (CAGR), from $8.46M to $73.16M.
- What does change in AR mean?
- Increase or decrease in amounts owed by customers — the primary working capital driver for many businesses.